Switch to:
GuruFocus has detected 7 Warning Signs with Medtronic PLC $MDT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Medtronic PLC (NYSE:MDT)
Research & Development
$2,215 Mil (TTM As of Jan. 2017)

This is the expense the company spent on research and development. Medtronic PLC's research and development for the three months ended in Jan. 2017 was $530 Mil. Its research and development for the trailing twelve months (TTM) ended in Jan. 2017 was $2,215 Mil.


Definition

This is the expense the company spent on research and development.

Medtronic PLC Research & Development for the trailing twelve months (TTM) ended in Jan. 2017 was 575 (Apr. 2016 ) + 556 (Jul. 2016 ) + 554 (Oct. 2016 ) + 530 (Jan. 2017 ) = $2,215 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Medtronic PLC Annual Data

Apr07Apr08Apr09Apr10Apr11Apr12Apr13Apr14Apr15Apr16
Research & Development 1,2391,2751,3551,4601,4721,4901,5571,4771,6402,224

Medtronic PLC Quarterly Data

Oct14Jan15Apr15Jul15Oct15Jan16Apr16Jul16Oct16Jan17
Research & Development 374373528558545546575556554530
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK